{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:03:23Z","timestamp":1789506203470,"version":"build-2803163510"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"UNIVERSITY RESEARCH FELLOWSHIP","award":["C2\/14013\/2024"],"award-info":[{"award-number":["C2\/14013\/2024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02859-2","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:29:27Z","timestamp":1751002167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Emerging roles and clinical perspectives of long noncoding RNAs in prostate cancer"],"prefix":"10.1007","volume":"42","author":[{"given":"Rajarethinam","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saradhadevi","family":"Muthukrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"2859_CR1","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27:5730.","journal-title":"Molecules"},{"key":"2859_CR2","first-page":"313","volume":"70","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;70:313.","journal-title":"CA Cancer J Clin"},{"key":"2859_CR3","doi-asserted-by":"crossref","unstructured":"Manorom D. Trends and projections in prostate cancer epidemiology in Thailand: A population-based cancer registry analysis. Asian J Urol. 2025; https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214388225000347.","DOI":"10.1016\/j.ajur.2025.03.005"},{"key":"2859_CR4","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1002\/mco2.265","volume":"4","author":"Z-N Lei","year":"2023","unstructured":"Lei Z-N, Tian Q, Teng Q-X, Wurpel JND, Zeng L, Pan Y, et al. Understanding and targeting resistance mechanisms in cancer. MedComm. 2023;4:e265.","journal-title":"MedComm"},{"key":"2859_CR5","doi-asserted-by":"publisher","first-page":"765207","DOI":"10.1155\/2014\/765207","volume":"2014","author":"JMA Pickl","year":"2014","unstructured":"Pickl JMA, Heckmann D, Ratz L, Klauck SM, S\u00fcltmann H. Novel RNA markers in prostate cancer: functional considerations and clinical translation. Biomed Res Int. 2014;2014:765207.","journal-title":"Biomed Res Int"},{"key":"2859_CR6","doi-asserted-by":"publisher","first-page":"154666","DOI":"10.1016\/j.prp.2023.154666","volume":"248","author":"R Haghighi","year":"2023","unstructured":"Haghighi R, Castillo-Acobo RY, Amin AH, Ehymayed HM, Alhili F, Mirzaei M, et al. A thorough understanding of the role of lncRNA in prostate cancer pathogenesis; Ccurrent knowledge and future research directions. Pathol Res Pract. 2023;248:154666.","journal-title":"Pathol Res Pract"},{"key":"2859_CR7","doi-asserted-by":"publisher","first-page":"e220247","DOI":"10.1530\/ERC-22-0247","volume":"30","author":"M Sattari","year":"2023","unstructured":"Sattari M, Kohvakka A, Moradi E, Rauhala H, Urhonen H, Isaacs WB, et al. Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases. Endocr Relat Cancer. 2023;30:e220247.","journal-title":"Endocr Relat Cancer"},{"key":"2859_CR8","first-page":"57","volume":"21","author":"M Taheri","year":"2024","unstructured":"Taheri M, Safarzadeh A, Ghafouri-Fard S, Baniahmad A. An in-silico approach for recognition of long non-coding RNA-associated competing endogenous RNA axes in prostate cancer. Urol J. 2024;21:57\u201373.","journal-title":"Urol J"},{"key":"2859_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1515\/hsz-2014-0201","volume":"395","author":"M Weiss","year":"2014","unstructured":"Weiss M, Plass C, Gerhauser C. Role of lncRNAs in prostate cancer development and progression. Biol Chem. 2014;395:1275\u201390.","journal-title":"Biol Chem"},{"key":"2859_CR10","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1002\/ctm2.426","volume":"11","author":"C Lang","year":"2021","unstructured":"Lang C, Yin C, Lin K, Li Y, Yang Q, Wu Z, et al. m(6) A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Transl Med. 2021;11:e426.","journal-title":"Clin Transl Med"},{"key":"2859_CR11","doi-asserted-by":"publisher","first-page":"100067","DOI":"10.1016\/j.adcanc.2022.100067","volume":"6","author":"P Anil","year":"2022","unstructured":"Anil P, Ghosh Dastidar S, Banerjee S. Unravelling the role of long non-coding RNAs in prostate carcinoma. Adv Cancer Biol Metastasis. 2022;6:100067.","journal-title":"Adv Cancer Biol Metastasis"},{"key":"2859_CR12","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.1007\/s00210-024-03736-x","volume":"398","author":"H Elimam","year":"2025","unstructured":"Elimam H, Zaki MB, Abd-Elmawla MA, Darwish HA, Hatawsh A, Aborehab NM, et al. Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:6349\u201368.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2859_CR13","doi-asserted-by":"publisher","first-page":"94358","DOI":"10.18632\/oncotarget.21719","volume":"81","author":"Y Du","year":"2017","unstructured":"Du Y, Weng XD, Wang L, Liu XH, Zhu HC, Guo J, et al. LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression. Oncotarget. 2017;81:94358.","journal-title":"Oncotarget"},{"key":"2859_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08975","volume":"464","author":"RA Gupta","year":"2010","unstructured":"Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071\u20136.","journal-title":"Nature"},{"key":"2859_CR15","doi-asserted-by":"publisher","first-page":"660853","DOI":"10.3389\/fcell.2021.660853","volume":"9","author":"Y Yang","year":"2021","unstructured":"Yang Y, Liu KY, Liu Q, Cao Q. Androgen receptor-related non-coding RNAs in prostate cancer. Front cell Dev Biol. 2021;9:660853.","journal-title":"Front cell Dev Biol"},{"key":"2859_CR16","doi-asserted-by":"publisher","first-page":"17861","DOI":"10.1074\/jbc.M116.718536","volume":"291","author":"A Misawa","year":"2016","unstructured":"Misawa A, Takayama KI, Urano T, Inoue S. Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes cell growth and inhibits apoptosis in prostate cancer cells. J Biol Chem. 2016;291:17861\u201380.","journal-title":"J Biol Chem"},{"key":"2859_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-017-0711-y","volume":"16","author":"W Su","year":"2017","unstructured":"Su W, Xu M, Chen X, Chen N, Gong J, Nie L, et al. Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer. Mol Cancer. 2017;16:142.","journal-title":"Mol Cancer"},{"key":"2859_CR18","doi-asserted-by":"publisher","first-page":"e81929","DOI":"10.7554\/eLife.81929","volume":"12","author":"RC Lauer","year":"2023","unstructured":"Lauer RC, Barry M, Smith TL, Thomas AM, Wu J, Du R, et al. Dysregulation of the PRUNE2\/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts. Elife. 2023;12:e81929.","journal-title":"Elife"},{"key":"2859_CR19","first-page":"29","volume":"394","author":"F Aguilo","year":"2016","unstructured":"Aguilo F, Di Cecilia S, Walsh MJ. Long non-coding RNA ANRIL and polycomb in human cancers and cardiovascular disease. Curr Top Microbiol Immunol. 2016;394:29\u201339.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2859_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-020-01293-4","volume":"19","author":"S Wen","year":"2020","unstructured":"Wen S, Wei Y, Zen C, Xiong W, Niu Y, Zhao Y. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine. Mol Cancer. 2020;19:171.","journal-title":"Mol Cancer"},{"key":"2859_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fonc.2017.00305","volume":"7","author":"A Cimadamore","year":"2017","unstructured":"Cimadamore A, Gasparrini S, Mazzucchelli R, Doria A, Cheng L, Lopez-Beltran A, et al. Long non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression. Front Oncol. 2017;7:305.","journal-title":"Front Oncol"},{"key":"2859_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nature12451","volume":"500","author":"L Yang","year":"2013","unstructured":"Yang L, Lin C, Jin C, Yang JC, Tanasa B, Li W, et al. LncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature. 2013;500:598\u2013602.","journal-title":"Nature"},{"key":"2859_CR23","doi-asserted-by":"publisher","first-page":"8403","DOI":"10.1073\/pnas.1507882112","volume":"112","author":"A Salameh","year":"2015","unstructured":"Salameh A, Lee AK, Card\u00f3-Vila M, Nunes DN, Efstathiou E, Staquicini FI, et al. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci USA. 2015;112:8403\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2859_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/cancers16030523","volume":"16","author":"S Maekawa","year":"2024","unstructured":"Maekawa S, Takata R, Obara W. Molecular mechanisms of prostate cancer development in the precision medicine era: a comprehensive review. Cancers (Basel). 2024;16:523.","journal-title":"Cancers (Basel)"},{"key":"2859_CR25","doi-asserted-by":"publisher","first-page":"697083","DOI":"10.3389\/fimmu.2021.697083","volume":"12","author":"Y-N Pi","year":"2021","unstructured":"Pi Y-N, Qi W-C, Xia B-R, Lou G, Jin W-L. Long non-coding RNAs in the tumor immune microenvironment: biological properties and therapeutic potential. Front Immunol. 2021;12:697083.","journal-title":"Front Immunol"},{"key":"2859_CR26","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1109\/TCBB.2021.3095369","volume":"19","author":"SJ Yeh","year":"2022","unstructured":"Yeh SJ, Chen BS. Systems medicine design based on systems biology approaches and deep neural network for gastric cancer. IEEE\/ACM Trans Comput Biol Bioinform. 2022;19:3019\u201331.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"2859_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3892\/ijmm.2021.5015","volume":"48","author":"Q Xie","year":"2021","unstructured":"Xie Q, Zhao S, Kang R, Wang X. lncRNA SNHG11 facilitates prostate cancer progression through the upregulation of IGF-1R expression and by sponging miR-184. Int J Mol Med. 2021;48:182.","journal-title":"Int J Mol Med"},{"key":"2859_CR28","doi-asserted-by":"publisher","first-page":"41045","DOI":"10.18632\/oncotarget.5728","volume":"6","author":"D Wang","year":"2015","unstructured":"Wang D, Ding L, Wang L, Zhao Y, Sun Z, Karnes RJ, et al. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castrationresistant prostate cancer. Oncotarget. 2015;6:41045.","journal-title":"Oncotarget"},{"key":"2859_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.eururo.2017.04.005","volume":"72","author":"R Wang","year":"2017","unstructured":"Wang R, Sun Y, Li L, Niu Y, Lin W, Lin C, et al. Preclinical study using malat1 small interfering RNA or androgen receptor splicing variant 7 degradation enhancer ASC-J9\u00ae to suppress enzalutamide-resistant prostate cancer progression. Eur Urol. 2017;72:835\u201344.","journal-title":"Eur Urol"},{"key":"2859_CR30","doi-asserted-by":"publisher","first-page":"15481","DOI":"10.18632\/oncotarget.7139","volume":"7","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Zhou N, Huang J, Ho TT, Zhu Z, Qiu Z, et al. Regulation of androgen receptor splice variant AR3 by PCGEM1. Oncotarget. 2016;7:15481.","journal-title":"Oncotarget"},{"key":"2859_CR31","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41588-018-0120-1","volume":"50","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Pitchiaya S, Cie\u015blik M, Niknafs YS, Tien JCY, Hosono Y, et al. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. Nat Genet. 2018;50:814\u201324.","journal-title":"Nat Genet"},{"key":"2859_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.celrep.2015.08.069","volume":"13","author":"A Zhang","year":"2015","unstructured":"Zhang A, Zhao JC, Kim J, Fong K, Yang YA, Chakravarti D, et al. LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep. 2015;13:209\u201321.","journal-title":"Cell Rep"},{"key":"2859_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12935-022-02637-4","volume":"22","author":"C Yu","year":"2022","unstructured":"Yu C, Fan Y, Zhang Y, Liu L, Guo G. LINC00893 inhibits the progression of prostate cancer through miR-3173-5p\/SOCS3\/JAK2\/STAT3 pathway. Cancer Cell Int. 2022;22:228.","journal-title":"Cancer Cell Int"},{"key":"2859_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1055\/a-1891-6864","volume":"54","author":"R Hu","year":"2022","unstructured":"Hu R, Wu P, Liu J. LncRNA MAGI2-AS3 inhibits prostate cancer progression by targeting the miR-142\u20133p. Horm Metab Res = Horm und Stoffwechselforsch = Horm Metab. 2022;54:754\u20139.","journal-title":"Horm Metab Res = Horm und Stoffwechselforsch = Horm Metab"},{"key":"2859_CR35","doi-asserted-by":"publisher","first-page":"1018107","DOI":"10.1016\/j.compbiomed.2024.108107","volume":"171","author":"Y Liu","year":"2024","unstructured":"Liu Y, Huang S, Dong G, Hou C, Zhao Y, Zhang D. Computational identification of DNA damage-relevant lncRNAs for predicting therapeutic efficacy and clinical outcomes in cancer. Comput Biol Med. 2024;171:1018107.","journal-title":"Comput Biol Med"},{"key":"2859_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12967-025-06294-9","volume":"23","author":"Y Wu","year":"2025","unstructured":"Wu Y, Cheng S, Zhang T, Wang L, Li T, Zheng Y, et al. A novel lncRNA FLJ promotes castration resistance in prostate cancer through AR mediated autophagy. J Transl Med. 2025;23:255.","journal-title":"J Transl Med"},{"key":"2859_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-019-1037-8","volume":"18","author":"P Gu","year":"2019","unstructured":"Gu P, Chen X, Xie R, Xie W, Huang L, Dong W, et al. A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer. Mol Cancer. 2019;18:109.","journal-title":"Mol Cancer"},{"key":"2859_CR38","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1158\/1541-7786.MCR-18-0087","volume":"16","author":"S Lingadahalli","year":"2018","unstructured":"Lingadahalli S, Jadhao S, Sung YY, Chen M, Hu L, Chen X, et al. Novel lncRNA LINC00844 regulates prostate cancer cell migration and invasion through AR signaling. Mol Cancer Res. 2018;16:1865\u201378.","journal-title":"Mol Cancer Res"},{"key":"2859_CR39","doi-asserted-by":"publisher","first-page":"eadk6989","DOI":"10.1126\/sciadv.adk6989","volume":"11","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wang T-Y, Li Q, Lu J, Ren Y, Weiner AB, et al. Androgen receptor-regulated lncRNA PRCAT71 promotes AR signaling through the interaction with KHSRP in prostate cancer. Sci Adv. 2025;11:eadk6989.","journal-title":"Sci Adv"},{"key":"2859_CR40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13046-024-03233-2","volume":"43","author":"J Kallenbach","year":"2024","unstructured":"Kallenbach J, Rasa M, Heidari Horestani M, Atri Roozbahani G, Schindler K, Baniahmad A. The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer. J Exp Clin Cancer Res. 2024;43:321.","journal-title":"J Exp Clin Cancer Res"},{"key":"2859_CR41","doi-asserted-by":"publisher","first-page":"e1531","DOI":"10.1002\/ctm2.1531","volume":"14","author":"Y Cai","year":"2024","unstructured":"Cai Y, Chen M, Gong Y, Tang G, Shu Z, Chen J, et al. Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor. Clin Transl Med. 2024;14:e1531.","journal-title":"Clin Transl Med"},{"key":"2859_CR42","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1097\/JS9.0000000000002334","volume":"111","author":"M Taheri","year":"2025","unstructured":"Taheri M, Schindler K, Baniahmad A. The lncRNAs PART1 and ADAMTS9-AS2 act in an antithetic manner on AR signaling and induction of cellular senescence in prostate cancer cells. Int J Surg. 2025;111:3646\u201364.","journal-title":"Int J Surg"},{"key":"2859_CR43","doi-asserted-by":"publisher","first-page":"101959","DOI":"10.1016\/j.bbrep.2025.101959","volume":"42","author":"B Khilwani","year":"2025","unstructured":"Khilwani B, Kour B, Shukla N, Vuree S, Ansari AS, Lohiya NK, et al. Characterization of lncRNA-protein interactions associated with Prostate cancer and Androgen receptors by molecular docking simulations. Biochem Biophys reports. 2025;42:101959.","journal-title":"Biochem Biophys reports"},{"key":"2859_CR44","doi-asserted-by":"publisher","first-page":"104275","DOI":"10.1016\/j.critrevonc.2024.104275","volume":"196","author":"Z Ke","year":"2024","unstructured":"Ke Z, Hu X, Liu Y, Shen D, Khan MI, Xiao J. Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers. Crit Rev Oncol Hematol. 2024;196:104275.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2859_CR45","doi-asserted-by":"publisher","first-page":"101730","DOI":"10.1016\/j.tranon.2023.101730","volume":"35","author":"KR Uppaluri","year":"2023","unstructured":"Uppaluri KR, Challa HJ, Gaur A, Jain R, Krishna Vardhani K, Geddam A, et al. Unlocking the potential of non-coding RNAs in cancer research and therapy. Transl Oncol. 2023;35:101730.","journal-title":"Transl Oncol"},{"key":"2859_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mce.2017.02.008","volume":"462","author":"JA Schneider","year":"2018","unstructured":"Schneider JA, Logan SK. Revisiting the role of Wnt\/\u03b2-catenin signaling in prostate cancer. Mol Cell Endocrinol. 2018;462:3\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"2859_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10142-025-01526-z","volume":"25","author":"AS Doghish","year":"2025","unstructured":"Doghish AS, Mageed SSA, Zaki MB, Abd-Elmawla MA, Sayed GA, Hatawsh A, et al. Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways. Funct Integr Genomics. 2025;25:16.","journal-title":"Funct Integr Genomics"},{"key":"2859_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41420-023-01585-w","volume":"9","author":"M Wang","year":"2023","unstructured":"Wang M, Yin C, Wu Z, Wang X, Lin Q, Jiang X, et al. The long transcript of lncRNA TMPO-AS1 promotes bone metastases of prostate cancer by regulating the CSNK2A1\/DDX3X complex in Wnt\/\u03b2-catenin signaling. Cell Death Discov. 2023;9:287.","journal-title":"Cell Death Discov"},{"key":"2859_CR49","doi-asserted-by":"publisher","first-page":"85502","DOI":"10.18632\/oncotarget.13453","volume":"7","author":"M Gao","year":"2016","unstructured":"Gao M, Zhang X, Li D, He P, Tian W, Zeng B. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma. Oncotarget. 2016;7:85502\u201314.","journal-title":"Oncotarget"},{"key":"2859_CR50","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3390\/cancers15061902","volume":"15","author":"B Chen","year":"2023","unstructured":"Chen B, Xu K, Zhang Y, Xu P, Li C, Liu J, et al. LncRNA ERVH48-1 contributes to the drug resistance of prostate cancer and proliferation through sponging of miR-4784 to the activation of the Wnt\/\u03b2-catenin pathway. Cancers (Basel). 2023;15:1902.","journal-title":"Cancers (Basel)"},{"key":"2859_CR51","doi-asserted-by":"publisher","first-page":"152537","DOI":"10.1016\/j.prp.2019.152537","volume":"215","author":"Y Han","year":"2019","unstructured":"Han Y, Hu H, Zhou J. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p\/WNT2B axis in vitro. Pathol Res Pract. 2019;215:152537.","journal-title":"Pathol Res Pract"},{"key":"2859_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12935-020-01280-1","volume":"20","author":"L Meng","year":"2020","unstructured":"Meng L, Li Z, Chen Y, Liu D, Liu Z. LINC00689 promotes prostate cancer progression via regulating miR-496\/CTNNB1 to activate Wnt pathway. Cancer Cell Int. 2020;20:215.","journal-title":"Cancer Cell Int"},{"key":"2859_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/ol.2020.11958","volume":"20","author":"P He","year":"2020","unstructured":"He P, Xiong G, Guo W, Jiang G, Li Y, Li H. Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt\/\u03b2-catenin signaling pathway. Oncol Lett. 2020;20:97.","journal-title":"Oncol Lett"},{"key":"2859_CR54","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.7150\/ijbs.104598","volume":"21","author":"Y Yin","year":"2025","unstructured":"Yin Y, Sun Y, Yao H, Yu F, Jia Q, Hu C, et al. TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the \u03b2-catenin-c-MYC-GLUT1 axis. Int J Biol Sci. 2025;21:1932\u201348.","journal-title":"Int J Biol Sci"},{"key":"2859_CR55","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1002\/tox.23656","volume":"37","author":"X Ma","year":"2022","unstructured":"Ma X, Ren H, Zhang Y, Wang B, Ma H. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p\/EGFR\/PI3K\/AKT\/mTOR signaling pathway. Environ Toxicol. 2022;37:3013\u201327.","journal-title":"Environ Toxicol"},{"key":"2859_CR56","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41417-024-00822-3","volume":"31","author":"A Kohvakka","year":"2024","unstructured":"Kohvakka A, Sattari M, N\u00e4ttinen J, Aapola U, Gregorov\u00e1 P, Tammela TLJ, et al. Long noncoding RNA EPCART regulates translation through PI3K\/AKT\/mTOR pathway and PDCD4 in prostate cancer. Cancer Gene Ther. 2024;31:1536\u201346.","journal-title":"Cancer Gene Ther"},{"key":"2859_CR57","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/21655979.2021.1890383","volume":"12","author":"X Ding","year":"2021","unstructured":"Ding X, Xu X, He X-F, Yuan Y, Chen C, Shen X-Y, et al. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN\/PI3K\/AKT\/mTOR signaling. Bioengineered. 2021;12:803\u201314.","journal-title":"Bioengineered"},{"key":"2859_CR58","first-page":"661","volume":"35","author":"T Ma","year":"2020","unstructured":"Ma T, Chen H, Wang P, Yang N, Bao J. Downregulation of lncRNA ZEB1-AS1 represses cell proliferation, migration, and invasion through mediating PI3K\/AKT\/mTOR signaling by miR-342-3p\/CUL4B axis in prostate cancer. Cancer Biother Radiopharm. 2020;35:661\u201372.","journal-title":"Cancer Biother Radiopharm"},{"key":"2859_CR59","doi-asserted-by":"publisher","first-page":"552907","DOI":"10.3389\/fonc.2020.552907","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Wang F, Xu H, Xu L, Chen D, Wang J, et al. Long non-coding RNA SNHG1 regulates the Wnt\/\u03b2-catenin and PI3K\/AKT\/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell. Front Oncol. 2020;10:552907.","journal-title":"Front Oncol"},{"key":"2859_CR60","doi-asserted-by":"publisher","first-page":"963689722112299","DOI":"10.1177\/09636897221122997","volume":"31","author":"Y Mao","year":"2022","unstructured":"Mao Y, Li W, Weng Y, Hua B, Gu X, Lu C, et al. METTL3-mediated m(6)A modification of lncRNA MALAT1 facilitates prostate cancer growth by activation of PI3K\/AKT signaling. Cell Transplant. 2022;31:9636897221122996.","journal-title":"Cell Transplant"},{"key":"2859_CR61","doi-asserted-by":"publisher","first-page":"9207148","DOI":"10.1155\/2023\/9207148","volume":"2023","author":"J Li","year":"2023","unstructured":"Li J, Huang X, Chen H, Gu C, Ni B, Zhou J. LINC01088\/miR-22\/CDC6 axis regulates prostate cancer progression by activating the PI3K\/AKT pathway. Mediators Inflamm. 2023;2023:9207148.","journal-title":"Mediators Inflamm"},{"key":"2859_CR62","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cbin.11194","volume":"43","author":"Y-C Wang","year":"2019","unstructured":"Wang Y-C, He W-Y, Dong C-H, Pei L, Ma Y-L. lncRNA HCG11 regulates cell progression by targeting miR-543 and regulating AKT\/mTOR pathway in prostate cancer. Cell Biol Int. 2019;43:1453\u201362.","journal-title":"Cell Biol Int"},{"key":"2859_CR63","doi-asserted-by":"publisher","first-page":"e3344","DOI":"10.1002\/jgm.3344","volume":"23","author":"W Sun","year":"2021","unstructured":"Sun W, Zu S, Shao G, Wang W, Gong F. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK\/PI3K\/AKT\/GSK3\u03b2\/snail pathway. J Gene Med. 2021;23:e3344.","journal-title":"J Gene Med"},{"key":"2859_CR64","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/ajco.13418","volume":"17","author":"S Yi","year":"2021","unstructured":"Yi S, Li G, Sun B. Overexpression of LINC00852 promotes prostate cancer cell proliferation and metastasis. Asia Pac J Clin Oncol. 2021;17:435\u201341.","journal-title":"Asia Pac J Clin Oncol"},{"key":"2859_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12032-022-01689-w","volume":"39","author":"C Liu","year":"2022","unstructured":"Liu C, Jiang S, Xie H, Jia H, Li R, Zhang K, et al. Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway. Med Oncol. 2022;39:94.","journal-title":"Med Oncol"},{"key":"2859_CR66","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/1878-0261.12634","volume":"14","author":"C Lang","year":"2020","unstructured":"Lang C, Dai Y, Wu Z, Yang Q, He S, Zhang X, et al. SMAD3\/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-\u03b2 signaling promotes prostate cancer bone metastasis. Mol Oncol. 2020;14:808\u201328.","journal-title":"Mol Oncol"},{"key":"2859_CR67","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3233\/CBM-170683","volume":"21","author":"B Zhao","year":"2018","unstructured":"Zhao B, Lu Y-L, Yang Y, Hu L-B, Bai Y, Li R-Q, et al. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a\/TGF-\u03b21\/ Smad signaling pathway. Cancer Biomark. 2018;21:613\u201320.","journal-title":"Cancer Biomark"},{"key":"2859_CR68","doi-asserted-by":"publisher","first-page":"10657","DOI":"10.2147\/CMAR.S231112","volume":"11","author":"B Li","year":"2019","unstructured":"Li B, Guo Z, Liang Q, Zhou H, Luo Y, He S, et al. lncRNA DGCR5 up-regulates TGF-\u03b21, increases cancer cell stemness and predicts survival of prostate cancer patients. Cancer Manag Res. 2019;11:10657\u201363.","journal-title":"Cancer Manag Res"},{"key":"2859_CR69","first-page":"4016","volume":"18","author":"H Zhang","year":"2019","unstructured":"Zhang H, Meng H, Huang X, Tong W, Liang X, Li J, et al. lncRNA MIR4435-2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF-\u03b21. Oncol Lett. 2019;18:4016\u201321.","journal-title":"Oncol Lett"},{"key":"2859_CR70","doi-asserted-by":"publisher","first-page":"9442","DOI":"10.18632\/aging.102395","volume":"11","author":"R Wang","year":"2019","unstructured":"Wang R, Zhang M, Ou Z, He W, Chen L, Zhang J, et al. Long noncoding RNA DNM3OS promotes prostate stromal cells transformation via the miR-29a\/29b\/COL3A1 and miR-361\/TGF\u03b21 axes. Aging (Albany NY). 2019;11:9442.","journal-title":"Aging (Albany NY)"},{"key":"2859_CR71","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7150\/jca.60749","volume":"13","author":"X Wei","year":"2022","unstructured":"Wei X, Hou Y, Zhang Y, Zhang H, Sun Z, Meng X, et al. Long non-coding RNA MAGI2-AS3 inactivates STAT3 pathway to inhibit prostate cancer cell proliferation via acting as a microRNA-424-5p sponge. J Cancer. 2022;13:343\u201353.","journal-title":"J Cancer"},{"key":"2859_CR72","doi-asserted-by":"publisher","first-page":"661431","DOI":"10.3389\/fonc.2021.661431","volume":"11","author":"H Jiang","year":"2021","unstructured":"Jiang H, Deng W, Zhu K, Zeng Z, Hu B, Zhou Z, et al. LINC00467 Promotes prostate cancer progression via M2 macrophage polarization and the miR-494-3p\/STAT3 axis. Front Oncol. 2021;11:661431.","journal-title":"Front Oncol"},{"key":"2859_CR73","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.ymthe.2020.06.013","volume":"28","author":"W Zhang","year":"2020","unstructured":"Zhang W, Shi X, Chen R, Zhu Y, Peng S, Chang Y, et al. Novel long non-coding RNA lncAMPC promotes metastasis and immunosuppression in prostate cancer by stimulating LIF\/LIFR expression. Mol Ther. 2020;28:2473\u201387.","journal-title":"Mol Ther"},{"key":"2859_CR74","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s11010-021-04284-1","volume":"477","author":"W Zhu","year":"2022","unstructured":"Zhu W, Sheng D, Shao Y, Zhang Q, Peng Y. STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression. Mol Cell Biochem. 2022;477:865\u201375.","journal-title":"Mol Cell Biochem"},{"key":"2859_CR75","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1093\/nar\/gkz108","volume":"47","author":"Z Shang","year":"2019","unstructured":"Shang Z, Yu J, Sun L, Tian J, Zhu S, Zhang B, et al. LncRNA PCAT1 activates AKT and NF-\u03baB signaling in castration-resistant prostate cancer by regulating the PHLPP\/FKBP51\/IKK\u03b1 complex. Nucleic Acids Res. 2019;47:4211\u201325.","journal-title":"Nucleic Acids Res"},{"key":"2859_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.02.078","volume":"601","author":"J Zhou","year":"2022","unstructured":"Zhou J, Li J, Qian C, Qiu F, Shen Q, Tong R, et al. LINC00624\/TEX10\/NF-\u03baB axis promotes proliferation and migration of human prostate cancer cells. Biochem Biophys Res Commun. 2022;601:1\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"2859_CR77","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1158\/0008-5472.CAN-19-3460","volume":"80","author":"S Saha","year":"2020","unstructured":"Saha S, Kiran M, Kuscu C, Chatrath A, Wotton D, Mayo MW, et al. Long noncoding RNA DRAIC inhibits prostate cancer progression by interacting with IKK to inhibit NF-\u03baB Aactivation. Cancer Res. 2020;80:950\u201363.","journal-title":"Cancer Res"},{"key":"2859_CR78","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.2147\/OTT.S286666","volume":"14","author":"S Deng","year":"2021","unstructured":"Deng S, Wang J, Zhang L, Li J, Jin Y. LncRNA HOTAIR promotes cancer stem-like cells properties by sponging miR-34a to activate the JAK2\/STAT3 pathway in pancreatic ductal adenocarcinoma. Onco Targets Ther. 2021;14:1883\u201393.","journal-title":"Onco Targets Ther"},{"key":"2859_CR79","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.neo.2014.09.001","volume":"16","author":"JR Prensner","year":"2014","unstructured":"Prensner JR, Chen W, Han S, Iyer MK, Cao Q, Kothari V, et al. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia. 2014;16:900\u20138.","journal-title":"Neoplasia"},{"key":"2859_CR80","doi-asserted-by":"publisher","first-page":"e23137","DOI":"10.1002\/jbt.23137","volume":"36","author":"W Li","year":"2022","unstructured":"Li W, Xu W, Sun K, Wang F, Wong TW, Kong A-N. Identification of novel biomarkers in prostate cancer diagnosis and prognosis. J Biochem Mol Toxicol. 2022;36:e23137.","journal-title":"J Biochem Mol Toxicol"},{"key":"2859_CR81","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/iub.2075","volume":"71","author":"T Bai","year":"2019","unstructured":"Bai T, Liu Y, Li B. LncRNA LOXL1-AS1\/miR-let-7a-5p\/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. IUBMB Life. 2019;71:1537\u201351.","journal-title":"IUBMB Life"},{"key":"2859_CR82","doi-asserted-by":"publisher","first-page":"1269233","DOI":"10.3389\/fphar.2023.1269233","volume":"14","author":"T Bu","year":"2023","unstructured":"Bu T, Li L, Tian J. Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway. Front Pharmacol. 2023;14:1269233.","journal-title":"Front Pharmacol"},{"key":"2859_CR83","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41419-019-1699-6","volume":"10","author":"X Wu","year":"2019","unstructured":"Wu X, Xiao Y, Zhou Y, Zhou Z, Yan W. LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4. Cell Death Dis. 2019;10:472.","journal-title":"Cell Death Dis"},{"key":"2859_CR84","doi-asserted-by":"publisher","first-page":"10627","DOI":"10.1111\/jcmm.17000","volume":"25","author":"N Peng","year":"2021","unstructured":"Peng N, Zhang Z, Wang Y, Yang M, Fan J, Wang Q, et al. Down-regulated LINC00115 inhibits prostate cancer cell proliferation and invasion via targeting miR-212-5p\/FZD5\/Wnt\/\u03b2-catenin axis. J Cell Mol Med. 2021;25:10627\u201337.","journal-title":"J Cell Mol Med"},{"key":"2859_CR85","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/biof.2083","volume":"50","author":"X Lian","year":"2024","unstructured":"Lian X, Zhou H, Liu S. Identification and validation of the TRHDE-AS1\/hsa-miR-449a\/ADAMTS5 axis as a novel prognostic biomarker in prostate cancer. BioFactors. 2024;50:1251\u201367.","journal-title":"BioFactors"},{"key":"2859_CR86","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2021.10.011","volume":"524","author":"V Mugoni","year":"2022","unstructured":"Mugoni V, Ciani Y, Nardella C, Demichelis F. Circulating RNAs in prostate cancer patients. Cancer Lett. 2022;524:57\u201369.","journal-title":"Cancer Lett"},{"key":"2859_CR87","first-page":"592","volume":"25","author":"H Zhou","year":"2023","unstructured":"Zhou H, Wan H, Feng Y, Zhu L, Mi Y. The diagnostic role and mechanistic functions of exosomal lncRNAs in prostate cancer. Clin Transl Oncol Off Publ Fed Spanish Oncol Soc Natl Cancer Inst Mex. 2023;25:592\u2013600.","journal-title":"Clin Transl Oncol Off Publ Fed Spanish Oncol Soc Natl Cancer Inst Mex"},{"key":"2859_CR88","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.3390\/ijms251810079","volume":"25","author":"M Stella","year":"2024","unstructured":"Stella M, Russo GI, Leonardi R, Carc\u00f2 D, Gattuso G, Falzone L, et al. Extracellular RNAs from whole urine to distinguish prostate cancer from benign prostatic hyperplasia. Int J Mol Sci. 2024;25:10079.","journal-title":"Int J Mol Sci"},{"key":"2859_CR89","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.3390\/ijms24054601","volume":"24","author":"F Tortora","year":"2023","unstructured":"Tortora F, La Civita E, Trivedi P, Febbraio F, Terracciano D, Cimmino A. Emerging RNA-based therapeutic and diagnostic options: recent advances and future challenges in genitourinary cancers. Int J Mol Sci. 2023;24:4601.","journal-title":"Int J Mol Sci"},{"key":"2859_CR90","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ncrna.2023.10.001","volume":"9","author":"N Tyagi","year":"2024","unstructured":"Tyagi N, Roy S, Vengadesan K, Gupta D. Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer. Non-coding RNA Res. 2024;9:66\u201375.","journal-title":"Non-coding RNA Res"},{"key":"2859_CR91","doi-asserted-by":"publisher","first-page":"e39406","DOI":"10.1097\/MD.0000000000039406","volume":"103","author":"X Liang","year":"2024","unstructured":"Liang X, Liu B. Exploration of PVT1 as a biomarker in prostate cancer. Medicine (Baltimore). 2024;103:e39406.","journal-title":"Medicine (Baltimore)"},{"key":"2859_CR92","first-page":"4531","volume":"13","author":"Z Xia","year":"2023","unstructured":"Xia Z, Wu J, Li Y, Yuan X, Sun J, Lv C, et al. LncRNA TYMSOS is a novel prognostic biomarker associated with immune infiltration in prostate cancer. Am J Cancer Res. 2023;13:4531\u201346.","journal-title":"Am J Cancer Res"},{"key":"2859_CR93","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.2174\/1389557523666230313144742","volume":"23","author":"X Lv","year":"2023","unstructured":"Lv X, Zhang M, Xu W. The value of emerging prostate cancer-associated lncRNA PCGEM1 in various tumors. Mini Rev Med Chem. 2023;23:2090\u20136.","journal-title":"Mini Rev Med Chem"},{"key":"2859_CR94","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/ijc.30546","volume":"140","author":"S Chandra Gupta","year":"2017","unstructured":"Chandra Gupta S, Nandan TY. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140:1955\u201367.","journal-title":"Int J Cancer"},{"key":"2859_CR95","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1159\/000488620","volume":"46","author":"Y-H Wang","year":"2018","unstructured":"Wang Y-H, Ji J, Wang B-C, Chen H, Yang Z-H, Wang K, et al. Tumor-derived exosomal long noncoding RNAs as promising diagnostic biomarkers for prostate cancer. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2018;46:532\u201345.","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"2859_CR96","doi-asserted-by":"publisher","first-page":"108860","DOI":"10.1016\/j.compbiomed.2024.108860","volume":"179","author":"B Sokouti","year":"2024","unstructured":"Sokouti B. The identification of biomarkers for Alzheimer\u2019s disease using a systems biology approach based on lncRNA-circRNA-miRNA-mRNA ceRNA networks. Comput Biol Med. 2024;179:108860.","journal-title":"Comput Biol Med"},{"key":"2859_CR97","doi-asserted-by":"publisher","first-page":"111104","DOI":"10.1016\/j.cellsig.2024.111104","volume":"117","author":"K Chen","year":"2024","unstructured":"Chen K, Zhang Y, Li C, Liu Y, Cao Q, Zhang X. Clinical value of molecular subtypes identification based on anoikis-related lncRNAs in castration-resistant prostate cancer. Cell Signal. 2024;117:111104.","journal-title":"Cell Signal"},{"key":"2859_CR98","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.urolonc.2020.06.003","volume":"38","author":"KK Shukla","year":"2020","unstructured":"Shukla KK, Misra S, Sankanagoudar S, Sharma H, Choudhary GR, Pareek P, et al. Recent scenario of long non-coding RNAs as a diagnostic and prognostic biomarkers of prostate cancer. Urol Oncol. 2020;38:918\u201328.","journal-title":"Urol Oncol"},{"key":"2859_CR99","doi-asserted-by":"publisher","first-page":"13153","DOI":"10.18632\/aging.202997","volume":"13","author":"J Li","year":"2021","unstructured":"Li J, Du H, Chen W, Qiu M, He P, Ma Z. Identification of potential autophagy-associated lncRNA in prostate cancer. Aging (Albany NY). 2021;13:13153\u201365.","journal-title":"Aging (Albany NY)"},{"key":"2859_CR100","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.1007\/s00432-023-04676-4","volume":"149","author":"Y Li","year":"2023","unstructured":"Li Y, Fang Z, Ge S, Li J, Qu L, Shi X, et al. Long non-coding RNA ENST00000503625 is a potential prognostic biomarker and metastasis suppressor gene in prostate cancer. J Cancer Res Clin Oncol. 2023;149:7305\u201317.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2859_CR101","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.21873\/invivo.13236","volume":"37","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, Kang SG, Kim CH. Over-expression of long non-coding RNA urothelial cancer-associated 1 as a predictive marker for prostate cancer. In Vivo. 2023;37:1511\u20136.","journal-title":"In Vivo"},{"key":"2859_CR102","doi-asserted-by":"publisher","first-page":"e23370","DOI":"10.1002\/jbt.23370","volume":"37","author":"S Zhou","year":"2023","unstructured":"Zhou S, Wu C, Tang Q, Zhou X, He B, Chang P, et al. Silencing LINC00491 inhibits prostate cancer development through the miR-384\/TRIM44 axis. J Biochem Mol Toxicol. 2023;37:e23370.","journal-title":"J Biochem Mol Toxicol"},{"key":"2859_CR103","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00432-025-06153-6","volume":"151","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Zhang Z, Zheng Y, Bai H, Wu X, Yang Y, et al. LncRNA LINC01128 promotes prostate cancer cell proliferation, metastasis, and epithelial-mesenchymal transition by modulating miR-27b-3p. J Cancer Res Clin Oncol. 2025;151:98.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2859_CR104","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/cancers12040771","volume":"12","author":"D Barros-Silva","year":"2020","unstructured":"Barros-Silva D, Lobo J, Guimar\u00e3es-Teixeira C, Carneiro I, Oliveira J, Martens-Uzunova ES, et al. VIRMA-dependent N6-methyladenosine modifications regulate the expression of long non-coding RNAs CCAT1 and CCAT2 in prostate cancer. Cancers (Basel). 2020;12:771.","journal-title":"Cancers (Basel)"},{"key":"2859_CR105","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1007\/s00210-024-03153-0","volume":"397","author":"RU Syed","year":"2024","unstructured":"Syed RU, Alshammari MD, Banu H, Khojali WMA, Jafar M, Nagaraju P, et al. Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:7421\u201337.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2859_CR106","doi-asserted-by":"publisher","first-page":"216247","DOI":"10.1016\/j.canlet.2023.216247","volume":"566","author":"K Gao","year":"2023","unstructured":"Gao K, Li X, Ni J, Wu B, Guo J, Zhang R, et al. Non-coding RNAs in enzalutamide resistance of castration-resistant prostate cancer. Cancer Lett. 2023;566:216247.","journal-title":"Cancer Lett"},{"key":"2859_CR107","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.3390\/ijms20122939","volume":"20","author":"T Saghafi","year":"2019","unstructured":"Saghafi T, Taheri RA, Parkkila S, Emameh RZ. Phytochemicals as modulators of long non-coding RNAs and inhibitors of cancer-related carbonic anhydrases. Int J Mol Sci. 2019;20:2939.","journal-title":"Int J Mol Sci"},{"key":"2859_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevEukaryotGeneExpr.2022042183","volume":"33","author":"S Yuan","year":"2023","unstructured":"Yuan S, Bi J, Zhang Y. LncRNA SSTR5-AS1 as a prognostic marker promotes cell proliferation and epithelial-to-mesenchymal transition in prostate cancer. Crit Rev Eukaryot Gene Expr. 2023;33:1\u201312.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"2859_CR109","doi-asserted-by":"publisher","first-page":"1085464","DOI":"10.3389\/fonc.2023.1085464","volume":"13","author":"S Song","year":"2023","unstructured":"Song S, Zhu Y, Zhang X, Chen S, Liu S. Prognostic values of long noncoding RNA in bone metastasis of prostate cancer: a systematic review and meta-analysis. Front Oncol. 2023;13:1085464.","journal-title":"Front Oncol"},{"key":"2859_CR110","first-page":"291","volume":"39","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Liu J, Wu Q, Song R, Miao W, Ma Y, et al. Long non-coding RNA AC008972.1 as a novel therapeutic target for prostate cancer. Cancer Biother Radiopharm. 2024;39:291\u2013305.","journal-title":"Cancer Biother Radiopharm"},{"key":"2859_CR111","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12894-024-01528-2","volume":"24","author":"Z Song","year":"2024","unstructured":"Song Z, Xu S, Gu X, Feng Q, Wang C. LncRNA PITPNA-AS1 mediates the diagnostic potential of miR-129-5p in prostate cancer. BMC Urol. 2024;24:146.","journal-title":"BMC Urol"},{"key":"2859_CR112","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.juro.2013.07.001","volume":"190","author":"S Ren","year":"2013","unstructured":"Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013;190:2278\u201387.","journal-title":"J Urol"},{"key":"2859_CR113","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1186\/s12885-024-12926-y","volume":"24","author":"X Li","year":"2024","unstructured":"Li X, Li Y, Zhang L, Long H. Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancer. BMC Cancer. 2024;24:1242.","journal-title":"BMC Cancer"},{"key":"2859_CR114","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.62347\/IMBV8599","volume":"14","author":"P-A Chen","year":"2024","unstructured":"Chen P-A, Chang P-C, Yeh WW, Hu T-Y, Hong Y-C, Wang Y-C, et al. The lncRNA TPT1-AS1 promotes the survival of neuroendocrine prostate cancer cells by facilitating autophagy. Am J Cancer Res. 2024;14:2103\u201323.","journal-title":"Am J Cancer Res"},{"key":"2859_CR115","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12672-024-00931-3","volume":"15","author":"L Cheng","year":"2024","unstructured":"Cheng L, Li S, Jiang D, Zhang J. DSCAM-AS1 promotes the development of prostate cancer. Discov Oncol. 2024;15:113.","journal-title":"Discov Oncol"},{"key":"2859_CR116","first-page":"e2408426","volume":"11","author":"C Hu","year":"2024","unstructured":"Hu C, Zheng Z, Pang S, Zhu Y, Jie J, Lai Z, et al. Chimeric SFT2D2-TBX19 promotes prostate cancer progression by encoding TBX19\u2013202 protein and stabilizing mitochondrial ATP synthase through ATP5F1A phosphorylation. Adv Sci (Weinheim, Baden-Wurttemberg Ger). 2024;11:e2408426.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg. Ger.)"},{"key":"2859_CR117","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13046-023-02774-2","volume":"42","author":"Q Dong","year":"2023","unstructured":"Dong Q, Qiu H, Piao C, Li Z, Cui X. LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a\/RREB1 positive feedback loop and a ceRNA network. J Exp Clin Cancer Res. 2023;42:209.","journal-title":"J Exp Clin Cancer Res"},{"key":"2859_CR118","first-page":"3983","volume":"13","author":"C-H Chang","year":"2023","unstructured":"Chang C-H, Cheng T-Y, Yeh WW, Luo Y-L, Campbell M, Kuo T-C, et al. REST-repressed lncRNA LINC01801 induces neuroendocrine differentiation in prostate cancer via transcriptional activation of autophagy. Am J Cancer Res. 2023;13:3983\u20134002.","journal-title":"Am J Cancer Res"},{"key":"2859_CR119","doi-asserted-by":"publisher","first-page":"e35631","DOI":"10.1097\/MD.0000000000035631","volume":"102","author":"Y Wu","year":"2023","unstructured":"Wu Y, Mou J, Liu Y, Zheng W. Association of LncRNA PCBP1-AS1 with cancer occurrence and development: a review. Medicine (Baltimore). 2023;102:e35631.","journal-title":"Medicine (Baltimore)"},{"key":"2859_CR120","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ajur.2024.01.007","volume":"11","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Wang Z, Li H, Ren Z, Zi T, Qin X, et al. LncRNA HCG18 promotes prostate cancer progression by regulating the miR-512-3p\/HK-2 axis. Asian J Urol. 2024;11:575\u201385.","journal-title":"Asian J Urol"},{"key":"2859_CR121","first-page":"637","volume":"38","author":"F Wang","year":"2023","unstructured":"Wang F, Zhao M, Jiang Y, Xia S, Sun D, Zhou D, et al. LncRNA UBE2R2-AS1, as prognostic marker, promotes cell proliferation and EMT in prostate cancer. Histol Histopathol. 2023;38:637\u201345.","journal-title":"Histol Histopathol"},{"key":"2859_CR122","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-0716-1354-2_9","volume":"2292","author":"R Gunelli","year":"2021","unstructured":"Gunelli R, Fragal\u00e0 E, Fiori M. PCA3 in Prostate Cancer. Methods Mol Biol. 2021;2292:105\u201313.","journal-title":"Methods Mol Biol"},{"key":"2859_CR123","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1158\/1541-7786.MCR-14-0257","volume":"12","author":"R Malik","year":"2014","unstructured":"Malik R, Patel L, Prensner JR, Shi Y, Iyer MK, Subramaniyan S, et al. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Mol Cancer Res. 2014;12:1081\u20137.","journal-title":"Mol Cancer Res"},{"key":"2859_CR124","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.2147\/CMAR.S170526","volume":"10","author":"L Dong","year":"2018","unstructured":"Dong L, Ding H, Li Y, Xue D, Liu Y. LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer. Cancer Manag Res. 2018;10:2799\u2013807.","journal-title":"Cancer Manag Res"},{"key":"2859_CR125","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12885-025-13746-4","volume":"25","author":"Y Wen","year":"2025","unstructured":"Wen Y, Zhan S, Wang S, Yang L, Yang S, Zheng S. LINC00657 exhibits oncogenic properties in prostate cancer and may serve as a prognostic biomarker in cancer. BMC Cancer. 2025;25:314.","journal-title":"BMC Cancer"},{"key":"2859_CR126","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/hmg\/ddt348","volume":"22","author":"D Weichenhan","year":"2013","unstructured":"Weichenhan D, Plass C. The evolving epigenome. Hum Mol Genet. 2013;22:R1-6.","journal-title":"Hum Mol Genet"},{"key":"2859_CR127","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13045-020-01005-x","volume":"13","author":"M Hong","year":"2020","unstructured":"Hong M, Tao S, Zhang L, Diao L-T, Huang X, Huang S, et al. RNA sequencing: new technologies and applications in cancer research. J Hematol Oncol. 2020;13:166.","journal-title":"J Hematol Oncol"},{"key":"2859_CR128","doi-asserted-by":"publisher","first-page":"D128","DOI":"10.1093\/nar\/gky960","volume":"47","author":"L Ma","year":"2019","unstructured":"Ma L, Cao J, Liu L, Du Q, Li Z, Zou D, et al. LncBook: a curated knowledgebase of human long non-coding RNAs. Nucleic Acids Res. 2019;47:D128\u201334.","journal-title":"Nucleic Acids Res"},{"key":"2859_CR129","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1016\/j.csbj.2022.08.003","volume":"20","author":"X Zhao","year":"2022","unstructured":"Zhao X, Lan Y, Chen D. Exploring long non-coding RNA networks from single cell omics data. Comput Struct Biotechnol J. 2022;20:4381\u20139.","journal-title":"Comput Struct Biotechnol J"},{"key":"2859_CR130","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41525-024-00401-3","volume":"9","author":"D Saha","year":"2024","unstructured":"Saha D, Dang HX, Zhang M, Quigley DA, Feng FY, Maher CA. Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer. NPJ Genomic Med. 2024;9:14.","journal-title":"NPJ Genomic Med"},{"key":"2859_CR131","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/nar\/gky1226","volume":"47","author":"N Rappoport","year":"2019","unstructured":"Rappoport N, Shamir R. Multi-omic and multi-view clustering algorithms: review and cancer benchmark. Nucleic Acids Res. 2019;47:1044.","journal-title":"Nucleic Acids Res"},{"key":"2859_CR132","doi-asserted-by":"publisher","first-page":"bbaa221","DOI":"10.1093\/bib\/bbaa221","volume":"22","author":"HC Rawal","year":"2021","unstructured":"Rawal HC, Angadi U, Mondal TK. TEnGExA: an R package based tool for tissue enrichment and gene expression analysis. Brief Bioinform. 2021;22:bbaa221.","journal-title":"Brief Bioinform"},{"key":"2859_CR133","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1631\/jzus.B2200206","volume":"24","author":"K Xu","year":"2023","unstructured":"Xu K, Jin X, Luo Y, Zou H, Lv D, Wang L, et al. Spatial transcriptome analysis of long non-coding RNAs reveals tissue specificity and functional roles in cancer. J Zhejiang Univ Sci B. 2023;24:15\u201331.","journal-title":"J Zhejiang Univ Sci B"},{"key":"2859_CR134","doi-asserted-by":"publisher","first-page":"1071972","DOI":"10.3389\/fcimb.2022.1071972","volume":"12","author":"J Tan","year":"2022","unstructured":"Tan J, Li X, Zhang L, Du Z. Recent advances in machine learning methods for predicting LncRNA and disease associations. Front Cell Infect Microbiol. 2022;12:1071972.","journal-title":"Front Cell Infect Microbiol"},{"key":"2859_CR135","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12672-024-01189-5","volume":"15","author":"C Dai","year":"2024","unstructured":"Dai C, Zeng X, Zhang X, Liu Z, Cheng S. Machine learning-based integration develops a mitophagy-related lncRNA signature for predicting the progression of prostate cancer: a bioinformatic analysis. Discov Oncol. 2024;15:316.","journal-title":"Discov Oncol"},{"key":"2859_CR136","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/ijms22020632","volume":"22","author":"K Taniue","year":"2021","unstructured":"Taniue K, Akimitsu N. The functions and unique features of LncRNAs in cancer development and tumorigenesis. Int J Mol Sci. 2021;22:632.","journal-title":"Int J Mol Sci"},{"key":"2859_CR137","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393\u2013407.","journal-title":"Cell"},{"key":"2859_CR138","doi-asserted-by":"publisher","first-page":"eaah7111","DOI":"10.1126\/science.aah7111","volume":"355","author":"SJ Liu","year":"2017","unstructured":"Liu SJ, Horlbeck MA, Cho SW, Birk HS, Malatesta M, He D, et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science. 2017;355:eaah7111.","journal-title":"Science"},{"key":"2859_CR139","doi-asserted-by":"publisher","first-page":"764","DOI":"10.18632\/oncotarget.1769","volume":"5","author":"F Crea","year":"2014","unstructured":"Crea F, Watahiki A, Quagliata L, Xue H, Pikor L, Parolia A, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 2014;5:764\u201374.","journal-title":"Oncotarget"},{"key":"2859_CR140","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2859_CR141","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics\u2014challenges and potential solutions. Nat Rev Drug Discov. 2021;20:629\u201351.","journal-title":"Nat Rev Drug Discov"},{"key":"2859_CR142","first-page":"558","volume":"18","author":"X Chen","year":"2017","unstructured":"Chen X, Yan CC, Zhang X, You ZH. Long non-coding RNAs and complex diseases: From experimental results to computational models. Brief Bioinform. 2017;18:558\u201376.","journal-title":"Brief Bioinform"},{"key":"2859_CR143","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/cas.13352","volume":"108","author":"A Misawa","year":"2017","unstructured":"Misawa A, Takayama K-I, Inoue S. Long non-coding RNAs and prostate cancer. Cancer Sci. 2017;108:2107\u201314.","journal-title":"Cancer Sci"},{"key":"2859_CR144","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jmoldx.2014.06.009","volume":"16","author":"B Lee","year":"2014","unstructured":"Lee B, Mazar J, Aftab MN, Qi F, Shelley J, Li J-L, et al. Long noncoding RNAs as putative biomarkers for prostate cancer detection. J Mol Diagn. 2014;16:615\u201326.","journal-title":"J Mol Diagn"},{"key":"2859_CR145","doi-asserted-by":"publisher","first-page":"326","DOI":"10.21037\/tau.2017.03.06","volume":"6","author":"AF Ghiam","year":"2017","unstructured":"Ghiam AF, Vesprini D, Liu SK. Long non-coding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer. Transl Androl Urol China. 2017;6:326\u201330.","journal-title":"Transl Androl Urol China"},{"key":"2859_CR146","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s42003-020-01120-y","volume":"3","author":"K-I Takayama","year":"2020","unstructured":"Takayama K-I, Fujimura T, Suzuki Y, Inoue S. Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors. Commun Biol. 2020;3:393.","journal-title":"Commun Biol"},{"key":"2859_CR147","first-page":"1","volume":"21","author":"M Amiri","year":"2024","unstructured":"Amiri M, Asadi Samani L, Kashi AH, Khadem N, Ziaee SAM, Mowla SJ. New molecular markers for prostate cancer diagnosis. Urol J. 2024;21:1\u201313.","journal-title":"Urol J"},{"key":"2859_CR148","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.18632\/oncotarget.1846","volume":"5","author":"JR Prensner","year":"2014","unstructured":"Prensner JR, Sahu A, Iyer MK, Malik R, Chandler B, Asangani IA, et al. The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Oncotarget. 2014;5:1434\u20138.","journal-title":"Oncotarget"},{"key":"2859_CR149","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinsk\u00e1 E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4:998\u20131013.","journal-title":"Cancer Discov"},{"key":"2859_CR150","doi-asserted-by":"publisher","first-page":"e27207","DOI":"10.1016\/j.heliyon.2024.e27207","volume":"10","author":"Y Shi","year":"2024","unstructured":"Shi Y, Adu-Amankwaah J, Zhao Q, Li X, Yu Q, Bushi A, et al. Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms. Heliyon. 2024;10:e27207.","journal-title":"Heliyon"},{"key":"2859_CR151","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-015-0314-4","volume":"14","author":"A Parolia","year":"2015","unstructured":"Parolia A, Crea F, Xue H, Wang Y, Mo F, Ramnarine VR, et al. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo. Mol Cancer. 2015;14:46.","journal-title":"Mol Cancer"},{"key":"2859_CR152","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","volume":"15","author":"M Ratti","year":"2020","unstructured":"Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, et al. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside. Target Oncol. 2020;15:261\u201378.","journal-title":"Target Oncol"},{"key":"2859_CR153","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.3390\/cancers13215350","volume":"13","author":"H Shaath","year":"2021","unstructured":"Shaath H, Elango R, Alajez NM. Molecular classification of breast cancer utilizing long non-coding RNA (lncRNA) transcriptomes identifies novel diagnostic lncRNA panel for triple-negative breast cancer. Cancers (Basel). 2021;13:5350.","journal-title":"Cancers (Basel)"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02859-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02859-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02859-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:02:58Z","timestamp":1757206978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02859-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":153,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2859"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02859-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no known competing financial interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Humans and animals' rights and informed consent"}}],"article-number":"289"}}